Also called: Kala-azar
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Leishmaniasis
Leishmaniasis is a parasitic disease spread by the bite of infected sand flies. There are several different forms of leishmaniasis. The most common are cutaneous and visceral. The cutaneous type causes skin sores. The visceral type affects internal organs such as the spleen, liver, and bone marrow. People with this form usually have fever, weight loss, and an enlarged spleen and liver.
Leishmaniasis is found in parts of about 88 countries. Most of these countries are in the tropics and subtropics. It is possible but very unlikely that you would get this disease in the United States. But you should be aware of it if you are traveling to the Middle East or parts of Central America, South America, Asia, Africa or southern Europe.
Treatment is with medicines that contain antimony, a type of metal, or with strong antibiotics. The best way to prevent the disease is to protect yourself from sand fly bites:
- Stay indoors from dusk to dawn, when sand flies are the most active
- Wear long pants and long-sleeved shirts when outside
- Use insect repellent and bed nets as needed
Centers for Disease Control and Prevention
It sits within Infections and Skin, Hair and Nails.
The lead U.S. institute for this subject is the National Institute of Allergy and Infectious Diseases.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Leishmaniasis
212 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Diagnosis and Treatment of Leishmania InfectionsNational Institute of Allergy and Infectious Diseases (NIAID)
- Comparison of Intralesional Glucantime With and Without Fractional CO₂ Laser in Adults With Cutaneous LeishmaniasisCombined military hospital Peshawar
- Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care SetupArmauer Hansen Research Institute, Ethiopia
- A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).Drugs for Neglected Diseases
- Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health WorkersKenya Medical Research Institute
- Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.Universidad de Antioquia
Research already completed
- Randomised Clinical Trial in Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in PakistanMedecins Sans Frontieres, Netherlands
- Human Bioequivalence Study of Liposomal Amphotericin B for InjectionSichuan Huiyu Pharmaceutical Co., Ltd
- Human Bioequivalence Study of Amphotericin B Liposome for InjectionSichuan Huiyu Pharmaceutical Co., Ltd
- A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral LeishmaniasisDrugs for Neglected Diseases
- Evaluation of CL Detect™ Rapid Test to Detect Cutaneous LeishmaniasisU.S. Army Medical Research and Development Command
- Ivermectin Repurposed for the Treatment of PKDLInternational Centre for Diarrhoeal Disease Research, Bangladesh
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- About LeishmaniasisCenters for Disease Control and Prevention
- LeishmaniasisNational Institute of Allergy and Infectious Diseases
Diagnosis and Tests
- Diagnosis of Parasitic DiseasesCenters for Disease Control and Prevention
Prevention and Risk Factors
- Preventing LeishmaniasisCenters for Disease Control and Prevention
Related Issues
- Travelers' Health: LeishmaniasisCenters for Disease Control and Prevention
Clinical Trials
- ClinicalTrials.gov: LeishmaniasisNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Leishmaniasis. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Leishmaniasis, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.